• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶状原位癌的多形性亚型:浸润性叶状癌的标志物还是前体?

The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?

机构信息

Department of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA.

出版信息

Ann Surg Oncol. 2011 Jul;18(7):1845-51. doi: 10.1245/s10434-011-1563-0. Epub 2011 Feb 2.

DOI:10.1245/s10434-011-1563-0
PMID:21287281
Abstract

BACKGROUND

Lobular carcinoma in situ (LCIS) is considered a risk factor-not a precursor-for both invasive lobular and ductal carcinoma. Florid LCIS (F-LCIS) is an architectural subtype of LCIS that does not express E-cadherin, yet has the histologic and often radiographic appearance of solid-type ductal carcinoma in situ (DCIS). Since DCIS is considered a precursor to invasive ductal carcinoma, should F-LCIS be considered a precursor to invasive lobular carcinoma (ILC)?

METHODS

Review of an institutional database identified cases of LCIS and solid-type DCIS diagnosed by excisional biopsy, segmentectomy, or mastectomy between 1991 and 2000 to determine the prevalence of associated invasive breast cancer. Archival specimens were evaluated for florid and nonflorid LCIS, nuclear grade of LCIS, and the presence and subtype of invasive breast cancer. Solid-type DCIS that lacked E-cadherin expression was classified as F-LCIS.

RESULTS

Of 210 consecutive specimens of LCIS examined, 171 had nonflorid LCIS (81%) and 39 had F-LCIS (19%). Nonflorid LCIS had a diffuse pattern, whereas F-LCIS appeared as discrete foci adjacent to ILC. An invasive component was identified with 87% of F-LCIS lesions versus 73% of nonflorid LCIS lesions (P = 0.064); this component was lobular in 100% of F-LCIS lesions versus 82% of nonflorid LCIS lesions, a significant difference (P = 0.0044) that persisted when the analysis was adjusted for nuclear grade (P = 0.0082).

CONCLUSION

Its close spatial relationship to an invasive component and increased association with ILC suggest that F-LCIS may be a precursor for ILC.

摘要

背景

乳腺小叶原位癌(LCIS)被认为是浸润性小叶癌和导管癌的危险因素,而非前体。富于细胞型 LCIS(F-LCIS)是 LCIS 的一种结构亚型,不表达 E-钙黏蛋白,但具有实性型导管原位癌(DCIS)的组织学和通常的影像学表现。由于 DCIS 被认为是浸润性导管癌的前体,那么 F-LCIS 是否也应该被认为是浸润性小叶癌(ILC)的前体呢?

方法

回顾性分析了 1991 年至 2000 年期间通过切除术、节段切除术或乳房切除术诊断的 LCIS 和实性 DCIS 的机构数据库,以确定相关浸润性乳腺癌的患病率。评估存档标本中的富于细胞型和非富于细胞型 LCIS、LCIS 的核级以及浸润性乳腺癌的存在和亚型。缺乏 E-钙黏蛋白表达的实性 DCIS 被归类为 F-LCIS。

结果

在检查的 210 例连续 LCIS 标本中,171 例为非富于细胞型 LCIS(81%),39 例为 F-LCIS(19%)。非富于细胞型 LCIS 呈弥漫性模式,而 F-LCIS 则表现为与 ILC 相邻的离散灶。F-LCIS 病变中 87%有浸润成分,而非富于细胞型 LCIS 病变中为 73%(P = 0.064);F-LCIS 病变中浸润成分全部为小叶癌,而非富于细胞型 LCIS 病变中为 82%,差异有统计学意义(P = 0.0044),当分析调整核级时,差异仍然具有统计学意义(P = 0.0082)。

结论

F-LCIS 与浸润成分的密切空间关系以及与 ILC 的更高关联提示其可能是 ILC 的前体。

相似文献

1
The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?叶状原位癌的多形性亚型:浸润性叶状癌的标志物还是前体?
Ann Surg Oncol. 2011 Jul;18(7):1845-51. doi: 10.1245/s10434-011-1563-0. Epub 2011 Feb 2.
2
Is there a low-grade precursor pathway in breast cancer?乳腺癌是否存在低度恶性前体途径?
Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.
3
Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.1988 - 2001年原位导管癌和原位小叶癌女性患者发生浸润性乳腺癌的风险
Cancer. 2006 May 15;106(10):2104-12. doi: 10.1002/cncr.21864.
4
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
5
Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?粗针活检发现小叶原位癌或非典型小叶增生:是否需要切除活检?
Radiology. 2004 Jun;231(3):813-9. doi: 10.1148/radiol.2313030874. Epub 2004 Apr 22.
6
[Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].[小叶原位癌(LCIS):浸润性小叶乳腺癌的危险因素及癌前病变]
Verh Dtsch Ges Pathol. 2007;91:208-13.
7
Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.同步小叶原位癌和浸润性小叶癌:浸润性小叶癌的标志物还是前驱病变
Eur J Surg Oncol. 2014 Oct;40(10):1245-9. doi: 10.1016/j.ejso.2014.04.007. Epub 2014 Apr 25.
8
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.95例乳腺非侵袭性导管和小叶病变的E-钙黏蛋白反应性。对疑难病变解读的意义。
Am J Clin Pathol. 2001 Apr;115(4):534-42. doi: 10.1309/B0DD-4M7H-GJG1-7KCW.
9
Lobular carcinoma in situ on core biopsy-what is the clinical significance?粗针活检发现的小叶原位癌——其临床意义是什么?
Clin Radiol. 2001 Mar;56(3):216-20. doi: 10.1053/crad.2000.0615.
10
Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.乳腺小叶原位癌患者中E-钙黏蛋白反应性的临床病理意义
Cancer. 2001 Aug 15;92(4):738-47.

引用本文的文献

1
Florid Lobular Carcinoma In Situ: Imaging Characteristics and Pathologic Upgrade Rates on Surgical Excision.小叶原位癌:手术切除的影像学特征及病理升级率
Breast J. 2025 Mar 30;2025:3580992. doi: 10.1155/tbj/3580992. eCollection 2025.
2
American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.美国病理学专家意见登记处:小叶原位癌的范围:诊断特征和临床意义。
Ann Diagn Pathol. 2020 Apr;45:151481. doi: 10.1016/j.anndiagpath.2020.151481. Epub 2020 Feb 15.
3
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
多形性和华丽型小叶原位癌变异体的遗传分析:ERBB2/ERBB3 改变频繁,与经典小叶原位癌和浸润性小叶癌存在克隆关系。
Mod Pathol. 2020 Jun;33(6):1078-1091. doi: 10.1038/s41379-019-0449-8. Epub 2020 Jan 6.
4
Quantitative expression of MMPs 2, 9, 14, and collagen IV in LCIS and paired normal breast tissue.LCIS 及配对正常乳腺组织中 MMPs 2、9、14 和胶原 IV 的定量表达。
Sci Rep. 2019 Sep 17;9(1):13432. doi: 10.1038/s41598-019-48602-6.
5
Treatment and survival outcomes of lobular carcinoma of the breast: a SEER population based study.乳腺小叶癌的治疗与生存结局:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Oncotarget. 2017 Oct 3;8(61):103047-103054. doi: 10.18632/oncotarget.21461. eCollection 2017 Nov 28.
6
Pleomorphic lobular carcinoma : Current evidence and a systemic review.多形性小叶癌:当前证据及系统评价
Oncol Lett. 2016 Dec;12(6):4863-4868. doi: 10.3892/ol.2016.5331. Epub 2016 Nov 1.
7
Molecular drivers of lobular carcinoma in situ.小叶原位癌的分子驱动因素。
Breast Cancer Res. 2015 Jun 4;17:76. doi: 10.1186/s13058-015-0580-5.
8
[Lobular neoplasms and invasive lobular breast cancer].[小叶性肿瘤与浸润性小叶癌]
Pathologe. 2014 Feb;35(1):45-53. doi: 10.1007/s00292-013-1840-8.
9
Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases.乳腺原位多形性小叶癌:47例临床病理回顾
Histopathology. 2014 Jun;64(7):981-93. doi: 10.1111/his.12353. Epub 2014 Feb 25.